Tumor marker test reagents used to detect tumor-related substances in the body. Their core function is to assist in the diagnosis of tumors, monitor treatment efficacy, and assess prognosis by detecting specific substances (such as proteins, hormones, enzymes, etc.) in blood, body fluids, or tissues. Alta DiagnoTech provides high-quality tumor marker test reagents to scientific research institutions, covering the entire demand chain from basic research to translational medicine.
Test Reagents Covering Multiple Tumor Markers
The following are some common tumor markers that can be detected by our products:
Cancer/Tumor |
Marker |
Liver cancer |
Alpha-fetoprotein (AFP), PIVKA-II |
Colorectal cancer |
Carcinoembryonic antigen (CEA), CA19-9 |
Stomach cancer |
CA72-4, CA19-9 |
Lung cancer |
Neuron-specific enolase (NSE), Cytokeratin 19 fragment (CYFRA21-1) |
Breast cancer |
CA15-3, HER2 |
Other |
Lactate dehydrogenase (LDH), BCL2 gene rearrangement, BRCA1 and BRCA2 gene mutations |
Supported Testing Platforms
Our tumor marker test reagents support a variety of testing platforms, including:
- Chemiluminescence immunoassay (CLIA)
- Enzyme-linked immunosorbent assay (ELISA)
- Fluorescent immunoassay (FIA)
- Electrochemiluminescence immunoassay (ECLIA)
- POCT (point-of-care testing)
Specific compatible models can be customized according to client needs.
Tumor Marker Test Reagent List
For more product information and formal quotations, please feel free to contact us at any time.